{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:16:01Z","timestamp":1793153761800,"version":"4.5.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Persistent symptoms after an infection have been described for a number of infectious diseases, including Lyme disease. Studies have confirmed a moderate but consistent increase in the prevalence of such symptoms after Lyme disease, though the risk increase varies dependent on study design and the definition of persistent symptoms. Various possible predictors have been proposed, including a dysregulation of the immune system, metabolic changes, increased sensitization to pain signals, cognitive-behavioral factors, or\u2014controversially\u2014the persistence of the causative Borrelia bacteria or remnants thereof. Research on the precise roles of any of these factors is still ongoing. The lack of biological underpinning also makes it difficult to assess with certainty which patients\u2019 (generally nonspecific) persistent symptoms are etiologically related to the previous Lyme disease episode and which are not, particularly as these symptoms occur in the general population relatively frequently. The diagnostic criteria for posttreatment Lyme disease syndrome have shown their usefulness in both clinical and research settings but leave out a number of patients whose symptoms may fall just outside said criteria. Though the relationship between these symptoms and the previous Lyme disease episode may be very uncertain, we would argue that a uniform description and classification of these patients will aid in future research and patient management, regardless of the eventual underlying cause. Thus, we argue for an inclusive classification system for all persistent symptoms attributed to Lyme disease in order to promote validation of patient experiences and perspectives, while also maintaining scientific nuance regarding the very uncertain etiology of these patients\u2019 symptoms.<\/jats:p>","DOI":"10.1093\/infdis\/jiae203","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T11:47:24Z","timestamp":1723636044000},"page":"S62-S69","source":"Crossref","is-referenced-by-count":13,"title":["Persistent Symptoms After Lyme Disease: Clinical Characteristics, Predictors, and Classification"],"prefix":"10.1093","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-3602","authenticated-orcid":false,"given":"M E","family":"Baarsma","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Amsterdam University Medical Center, University of Amsterdam , Amsterdam , The Netherlands"},{"name":"Amsterdam Institute for Immunology and Infectious Diseases , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joppe W","family":"Hovius","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Amsterdam University Medical Center, University of Amsterdam , Amsterdam , The Netherlands"},{"name":"Amsterdam Institute for Immunology and Infectious Diseases , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"2024081411465519500_jiae203-B1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka","year":"2022","journal-title":"Nat Med"},{"key":"2024081411465519500_jiae203-B2","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.ijid.2013.01.008","article-title":"Development of a foundation for a case definition of posttreatment Lyme disease syndrome","volume":"17","author":"Aucott","year":"2013","journal-title":"Int J Infect Dis"},{"key":"2024081411465519500_jiae203-B3","doi-asserted-by":"crossref","first-page":"m1041","DOI":"10.1136\/bmj.m1041","article-title":"Lyme borreliosis: diagnosis and management","volume":"369","author":"Kullberg","year":"2020","journal-title":"BMJ"},{"key":"2024081411465519500_jiae203-B4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2024081411465519500_jiae203-B5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.medmal.2018.11.011","article-title":"Review of European and American guidelines for the diagnosis of Lyme borreliosis","volume":"49","author":"Eldin","year":"2019","journal-title":"Med Mal Infect"},{"key":"2024081411465519500_jiae203-B6","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J Rheumatol"},{"key":"2024081411465519500_jiae203-B7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early Lyme disease","volume":"123","author":"Cerar","year":"2010","journal-title":"Am J Med"},{"key":"2024081411465519500_jiae203-B8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","article-title":"Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review","volume":"263","author":"Dersch","year":"2016","journal-title":"J Neurol"},{"key":"2024081411465519500_jiae203-B9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.2010.01482.x","article-title":"European neuroborreliosis: quality of life 30 months after treatment","volume":"124","author":"Eikeland","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"2024081411465519500_jiae203-B10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of study patients with Lyme disease, 10\u201320-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"J Infect Dis"},{"key":"2024081411465519500_jiae203-B11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","article-title":"Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors","volume":"17","author":"Lj\u00f8stad","year":"2010","journal-title":"Eur J Neurol"},{"key":"2024081411465519500_jiae203-B12","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/cid\/civ735","article-title":"Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease","volume":"61","author":"Weitzner","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024081411465519500_jiae203-B13","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1093\/cid\/ciz1215","article-title":"Prospective evaluation of the frequency and severity of symptoms in Lyme disease patients with erythema migrans compared with matched controls at baseline, 6 months, and 12 months","volume":"71","author":"Wormser","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024081411465519500_jiae203-B14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjmed.2014.09.022","article-title":"Long-term assessment of fatigue in patients with culture-confirmed Lyme disease","volume":"128","author":"Wormser","year":"2015","journal-title":"Am J Med"},{"key":"2024081411465519500_jiae203-B15","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.lanepe.2021.100142","article-title":"Prevalence of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study","volume":"6","author":"Ursinus","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2024081411465519500_jiae203-B16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12879-019-3949-8","article-title":"Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)","volume":"19","author":"Vrijmoeth","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2024081411465519500_jiae203-B17","doi-asserted-by":"crossref","first-page":"100340","DOI":"10.1016\/j.lanepe.2022.100340","article-title":"Concerns about the external validity of the study \u2018Prevalence of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.\u2019","volume":"15","author":"Dessau","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2024081411465519500_jiae203-B18","doi-asserted-by":"crossref","first-page":"100344","DOI":"10.1016\/j.lanepe.2022.100344","article-title":"Concerns about the external validity of the study \u2018prevalence of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study\u2019\u2014authors\u2019 reply","volume":"15","author":"van den Wijngaard","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2024081411465519500_jiae203-B19","doi-asserted-by":"crossref","first-page":"104825","DOI":"10.1016\/j.ebiom.2023.104825","article-title":"Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study","volume":"98","author":"Vrijmoeth","year":"2023","journal-title":"EBioMedicine"},{"key":"2024081411465519500_jiae203-B20","first-page":"756","article-title":"Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016\u20132020)","volume-title":"BMC Infect Dis","author":"Geebelen","year":"2022"},{"key":"2024081411465519500_jiae203-B21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijid.2022.01.033","article-title":"Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: a prospective cohort study","volume":"116","author":"Aucott","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2024081411465519500_jiae203-B22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/CVI.00071-16","article-title":"CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study","volume":"23","author":"Aucott","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"2024081411465519500_jiae203-B23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3201\/eid2906.221685","article-title":"Association of persistent symptoms after Lyme neuroborreliosis and increased levels of interferon-\u03b1 in blood","volume":"29","author":"Hern\u00e1ndez","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2024081411465519500_jiae203-B24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cid\/cit735","article-title":"Elevated levels of IL-23 in a subset of patients with post-Lyme disease symptoms following erythema migrans","volume":"58","author":"Strle","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024081411465519500_jiae203-B25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12974-018-1381-4","article-title":"Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [(11)C]DPA-713 PET","volume":"15","author":"Coughlin","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2024081411465519500_jiae203-B26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.neuropsych.12090223","article-title":"Post-treatment Lyme syndrome and central sensitization","volume":"25","author":"Batheja","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2024081411465519500_jiae203-B27","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1073\/pnas.1904170116","article-title":"Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis","volume":"116","author":"Jutras","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024081411465519500_jiae203-B28","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1172\/JCI58813","article-title":"Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy","volume":"122","author":"Bockenstedt","year":"2012","journal-title":"J Clin Invest"},{"key":"2024081411465519500_jiae203-B29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/cit810","article-title":"A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease","volume":"58","author":"Lantos","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024081411465519500_jiae203-B30","doi-asserted-by":"crossref","first-page":"e0007422","DOI":"10.1128\/cmr.00074-22","article-title":"Persistent Borrelia burgdorferi sensu lato infection after antibiotic treatment: systematic overview and appraisal of the current evidence from experimental animal models","volume":"35","author":"Verschoor","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"2024081411465519500_jiae203-B31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.amjmed.2009.02.022","article-title":"Psychiatric comorbidity and other psychological factors in patients with \u201cchronic Lyme disease.\u201d","volume":"122","author":"Hassett","year":"2009","journal-title":"Am J Med"},{"key":"2024081411465519500_jiae203-B32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S0025727300015842","article-title":"Eighteenth-century nosology and its survivors","volume":"14","author":"Fischer-Homberger","year":"1970","journal-title":"Med History"},{"key":"2024081411465519500_jiae203-B33"},{"key":"2024081411465519500_jiae203-B34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/287343","article-title":"What is disease?","volume":"21","author":"King","year":"1954","journal-title":"Philosophy Sci"},{"key":"2024081411465519500_jiae203-B35","doi-asserted-by":"crossref","first-page":"368.e11","DOI":"10.1016\/j.cmi.2014.11.014","article-title":"Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in the Netherlands","volume":"21","author":"Coumou","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2024081411465519500_jiae203-B36","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cmi.2020.09.022","article-title":"Suspicion of Lyme borreliosis in patients referred to an infectious diseases clinic: what did the patients really have?","volume":"27","author":"Kortela","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2024081411465519500_jiae203-B37","doi-asserted-by":"crossref","first-page":"101591","DOI":"10.1016\/j.ttbdis.2020.101591","article-title":"Classification of patients referred under suspicion of tick-borne diseases, Copenhagen, Denmark","volume":"12","author":"Gynthersen","year":"2021","journal-title":"Ticks Tick Borne Dis"},{"key":"2024081411465519500_jiae203-B38","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/cid\/ciy799","article-title":"Holistic approach in patients with presumed Lyme borreliosis leads to less than 10% of confirmation and more than 80% of antibiotic failures","volume":"68","author":"Haddad","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024081411465519500_jiae203-B39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.medmal.2018.06.002","article-title":"Multidisciplinary management of patients presenting with Lyme disease suspicion","volume":"49","author":"Jacquet","year":"2019","journal-title":"Med Maladies Infect"},{"key":"2024081411465519500_jiae203-B40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/qjmed\/hcs003","article-title":"Lyme disease in a British referral clinic","volume":"105","author":"Cottle","year":"2012","journal-title":"QJM"},{"key":"2024081411465519500_jiae203-B41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1468-1331.2010.03229.x","article-title":"The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis\u2014the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic","volume":"18","author":"Djukic","year":"2011","journal-title":"Eur J Neurol"},{"key":"2024081411465519500_jiae203-B42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cmi.2018.09.016","article-title":"Non-specific symptoms in adult patients referred to a Lyme centre","volume":"25","author":"Zomer","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2024081411465519500_jiae203-B43","doi-asserted-by":"crossref","first-page":"ofz299","DOI":"10.1093\/ofid\/ofz299","article-title":"Misdiagnosis of Lyme disease with unnecessary antimicrobial treatment characterizes patients referred to an academic infectious diseases clinic","volume":"6","author":"Kobayashi","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2024081411465519500_jiae203-B44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.amjmed.2021.10.040","article-title":"Mistaken identity: many diagnoses are frequently misattributed to Lyme disease","volume":"135","author":"Kobayashi","year":"2021","journal-title":"Am J Med"},{"key":"2024081411465519500_jiae203-B45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study","volume":"128","author":"Reid","year":"1998","journal-title":"Ann Intern Med"},{"key":"2024081411465519500_jiae203-B46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2296-15-79","article-title":"Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study","volume":"15","author":"Ali","year":"2014","journal-title":"BMC Family Pract"},{"key":"2024081411465519500_jiae203-B47","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.revmed.2018.04.002","article-title":"Cheminement diagnostique et v\u00e9cu des patients se pensant atteints de maladie de Lyme chronique","volume":"39","author":"Forestier","year":"2018","journal-title":"La Revue de M\u00e9d Int"},{"key":"2024081411465519500_jiae203-B48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/1049732315619380","article-title":"Living in limbo: contested narratives of patients with chronic symptoms following Lyme disease","volume":"27","author":"Rebman","year":"2017","journal-title":"Qual Health Res"},{"key":"2024081411465519500_jiae203-B49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12875-022-01736-5","article-title":"Knowing the entire story\u2014a focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease)","volume":"23","author":"Baarsma","year":"2022","journal-title":"BMC Prim Care"},{"key":"2024081411465519500_jiae203-B50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrrheum.2013.96","article-title":"Culture, science and the changing nature of fibromyalgia","volume":"9","author":"Wolfe","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2024081411465519500_jiae203-B51","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"key":"2024081411465519500_jiae203-B52"},{"key":"2024081411465519500_jiae203-B53","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/1471-0528.15272","article-title":"Variation in hyperemesis gravidarum definition and outcome reporting in randomised clinical trials: a systematic review","volume":"125","author":"Koot","year":"2018","journal-title":"BJOG"},{"key":"2024081411465519500_jiae203-B54","first-page":"983","article-title":"A core outcome set for hyperemesis gravidarum research: an international consensus study","volume-title":"BJOG","author":"Jansen","year":"2020"},{"key":"2024081411465519500_jiae203-B55","doi-asserted-by":"crossref","first-page":"ofad471","DOI":"10.1093\/ofid\/ofad471","article-title":"Prevalence of long-term symptoms varies when using different post-COVID-19 definitions in positively and negatively tested adults: the PRIME post-COVID study","volume":"10","author":"Pagen","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024081411465519500_jiae203-B56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1467-9566.2008.01152.x","article-title":"Sociology of diagnosis: a preliminary review","volume":"31","author":"Jutel","year":"2009","journal-title":"Sociol Health Illness"},{"key":"2024081411465519500_jiae203-B57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jpsychores.2015.09.003","article-title":"Still modern? Developing the biopsychosocial model for the 21st century","volume":"79","author":"Henningsen","year":"2015","journal-title":"J Psychosom Res"},{"key":"2024081411465519500_jiae203-B58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fmed.2020.00464","article-title":"Symptom clusters and functional impairment in individuals treated for Lyme borreliosis","volume":"7","author":"Zubcevik","year":"2020","journal-title":"Front Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/Supplement_1\/S62\/58817409\/jiae203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/Supplement_1\/S62\/58817409\/jiae203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T11:47:55Z","timestamp":1723636075000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/230\/Supplement_1\/S62\/7733438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":58,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2024,8,14]]},"published-print":{"date-parts":[[2024,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae203","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8,15]]},"published":{"date-parts":[[2024,8,14]]}}}